Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
William Banyai, a Senior Vice President at Twist Bioscience, sold 798 shares of common stock on May 3, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- On May 3, 2024, William Banyai, a Senior Vice President at Twist Bioscience, sold 798 shares of common stock.
- The sale was executed at a price of $37.134 per share.
- The purpose of the sale was to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- Following the transaction, Banyai directly owns 345,188 shares of Twist Bioscience.
- The sale was mandated by Twist Bioscience's equity incentive plan, requiring a 'sell to cover' transaction for tax obligations.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't reflect a change in the executive's confidence in the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of stock sale transaction |
| 05/07/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.